BioNTech

BioNTech Faces Pivotal Moment as Pfizer Cuts Stake

angelina - November 18, 2025

BioNTech’s Strategic Crossroads: High-Stakes Acquisition and Partnership Shifts

angelina - November 18, 2025

Pfizer Divests Majority Stake in BioNTech, Signaling Strategic Shift

kashif hafeez - November 15, 2025

BioNTech Shares Face Pressure as Pfizer Exits Stake

angelina - November 15, 2025

Pfizer’s Strategic Shift Sends Ripples Through BioNTech Investment

Brett Shapiro - November 13, 2025

BioNTech Shares: A Potential Turning Point?

kashif hafeez - November 11, 2025

BioNTech’s Strategic Pivot Gains Momentum with Major Oncology Partnership

November 9, 2025

BioNTech’s Strategic Shift Gains Momentum with Major Pharma Partnership

Brett Shapiro - November 8, 2025

BioNTech’s Strategic Pivot: From Pandemic Profits to Oncology Ambitions

angelina - November 7, 2025

BioNTech’s Strategic Pivot Shows Promise Amid Financial Rebound

angelina - November 7, 2025

BioNTech’s Strategic Pivot: Oncology Pipeline Takes Center Stage as Vaccine Revenue Declines

angelina - November 6, 2025

Can BioNTech Successfully Transition From Pandemic Success to Cancer Innovation?

Brett Shapiro - November 5, 2025

BioNTech’s Pivotal Moment: Q3 Earnings and Cancer Pipeline in Focus

kashif hafeez - November 2, 2025

12Page 2 of 2